TruScreen Group Limited confirmed the receipt of a further purchase order from Zimbabwe for SUS (single use sensor) with a gross sales value of approximately NZD 300,000. The SUS is the disposal consumable item used in each TruScreen cervical cancer screening test.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 NZD | 0.00% | +5.88% | -21.74% |
Mar. 13 | Truscreen Group Raises Additional NZ$520,000 via Share Placement; Shares Jump 5% | MT |
Mar. 08 | New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.74% | 6.08M | |
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |
- Stock Market
- Equities
- TRU Stock
- News TruScreen Group Limited
- TruScreen Group Limited Confirms Receipt of Further Purchase Order from Zimbabwe for SUS